Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
61.8M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
62.2M
-
Shares change
-
+2.67M
-
Total reported value, excl. options
-
$281M
-
Value change
-
+$12M
-
Put/Call ratio
-
0
-
Number of buys
-
76
-
Number of sells
-
-34
-
Price
-
$4.51
Significant Holders of Monte Rosa Therapeutics, Inc. - COMMON STOCK (GLUE) as of Q2 2025
135 filings reported holding GLUE - Monte Rosa Therapeutics, Inc. - COMMON STOCK as of Q2 2025.
Monte Rosa Therapeutics, Inc. - COMMON STOCK (GLUE) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.2M shares
.
Largest 10 shareholders include NEA Management Company, LLC (7.69M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6.33M shares), BVF INC/IL (5.66M shares), Versant Venture Management, LLC (5.65M shares), BAKER BROS. ADVISORS LP (4.92M shares), BlackRock, Inc. (3.85M shares), Avoro Capital Advisors LLC (3.73M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (3.36M shares), VANGUARD GROUP INC (3.14M shares), and FMR LLC (2.29M shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.